Comparison
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696 vs 3 Methylglutaric Aciduria C3151952
Clinical comparison between 46 XY Difference OF Sex Development Due TO A Defect IN Testosterone Metabolism BY Peripheral Tissue and 3 Methylglutaric Aciduria for differential diagnosis and treatment planning.
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
A condition where the body cannot properly convert testosterone to DHT in peripheral tissues. Affects 46,XY individuals, causing atypical genital development. Treatment involves hormone replacement.
3 Methylglutaric Aciduria C3151952
An organic acidemia affecting how the body processes certain amino acids. It can cause neurological problems and metabolic crises. Management involves dietary changes and supportive treatment.
6 comparison axes
Onset
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
0-0
3 Methylglutaric Aciduria C3151952
0-10
Onset patterns differ
Severity
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
severe
3 Methylglutaric Aciduria C3151952
moderate
Different severity levels
Chronic
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
Chronic
3 Methylglutaric Aciduria C3151952
Chronic
Differing course
Communicable
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
No
3 Methylglutaric Aciduria C3151952
No
Different transmission
Body System
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
reproductive
3 Methylglutaric Aciduria C3151952
metabolic
Same/different system
Category
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
endocrine
3 Methylglutaric Aciduria C3151952
metabolic
Different category
Bottom line
46-xy-difference-of-sex-development-due-to-a-defect-in-testosterone-metabolism-by-peripheral-tissue-C5816696 and 3-methylglutaric-aciduria-C3151952 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696 | 3 Methylglutaric Aciduria C3151952 | Discriminating power |
|---|---|---|---|
| Genital development | Atypical genital development may occur in 46,XY individuals. | Genital development is not the defining feature in the source. | High |
| Metabolic crisis | Not described as an amino-acid metabolic crisis. | Metabolic crises may occur; exact features are not established here. | High |
| Neurologic problems | Neurologic disease is not the supplied primary feature. | Neurologic problems may occur, with an unspecified spectrum. | Moderate |
When to favor each condition
Choose 46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696 when
Atypical genitalia in a 46,XY newborn
The source links this pattern to impaired peripheral testosterone-to-DHT conversion.
Moderate
Endocrine evaluation of sex development
The assigned category is endocrine and the body system reproductive.
High
Considering hormone replacement
Hormone replacement is mentioned, but regimen and dose are not established here.
Moderate
Choose 3 Methylglutaric Aciduria C3151952 when
Suspected organic acidemia
The source describes disordered processing of certain amino acids.
Moderate
Neurologic symptoms with metabolic illness
Neurologic problems and metabolic crises are both mentioned.
Moderate
Need for dietary metabolic care
Management is described as dietary change plus supportive treatment.
Moderate
How key tests differ
| Test | 46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696 | 3 Methylglutaric Aciduria C3151952 | Interpretation |
|---|---|---|---|
| Karyotype and genital assessment | 46,XY context with possible atypical genitalia. | No defining karyotype or genital pattern is supplied. | Supports classification only; it does not prove either diagnosis. |
| Targeted biochemical testing | Testosterone-to-DHT metabolism may be assessed; no cutoff is supplied. | Urine organic acids may show 3-methylglutaric acid; no cutoff is supplied. | An abnormal result is not itself a diagnosis and needs specialist review. |
| Genetic or metabolic confirmation | Endocrine or genetic testing may be considered. | Metabolic and genetic testing may clarify the aciduria. | Confirmation and subtype are not established by this comparison. |
Prognosis comparison
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
- Outcome
- Chronic condition; long-term outcome is variable and not quantified here.
- Factors
- Phenotype, hormone findings, and access to specialist care.
3 Methylglutaric Aciduria C3151952
- Outcome
- Chronic metabolic disorder with possible crises and neurologic effects.
- Factors
- Crisis pattern, neurologic involvement, and response to supportive care.
Time frame: From birth or childhood into long-term follow-up; exact course is not established.
Confirmed diagnosis, individual complications, and coordinated specialist care.
Complications comparison
| Complication | Presentation |
|---|---|
| Acute decompensation | Not described as a metabolic crisis disorder. Metabolic crises are possible; triggers and frequency are unspecified. Urgent assessment is appropriate for suspected metabolic decompensation. |
| Development and neurologic effects | Primary concern is sex development rather than defined neurologic disease. Neurologic problems may affect development, but severity varies. No mortality or disability rate is established in the source. |
| Long-term care needs | May involve hormone care and specialist sex-development follow-up. May involve diet, monitoring, and supportive care. Treatment details and doses are not provided and must be individualized. |
Patient education highlights
- HighSeparate conditions
These conditions affect different systems and should not be treated as interchangeable diagnoses.
- HighTest interpretation
An abnormal hormone or organic-acid result needs clinician confirmation before diagnosis.
- MediumWhen to seek care
Seek urgent care for suspected metabolic crisis; DSD care should be specialist-led and individualized.